Correlation Between X4 Pharmaceuticals and LENZ Therapeutics

Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and LENZ Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and LENZ Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between X4 Pharmaceuticals and LENZ Therapeutics, you can compare the effects of market volatilities on X4 Pharmaceuticals and LENZ Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of LENZ Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and LENZ Therapeutics.

Diversification Opportunities for X4 Pharmaceuticals and LENZ Therapeutics

-0.37

Correlation Coefficient

X4 Pharmaceuticals  LENZ Therapeutics

Very good diversification

The 3 months correlation between XFOR and LENZ is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and LENZ Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LENZ Therapeutics and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with LENZ Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LENZ Therapeutics has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and LENZ Therapeutics go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and LENZ Therapeutics

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to under-perform the LENZ Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, X4 Pharmaceuticals is 1.03 times less risky than LENZ Therapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The LENZ Therapeutics is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2,247  in LENZ Therapeutics on July 22, 2024 and sell it today you would earn a total of  552.00  from holding LENZ Therapeutics or generate 24.57% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

X4 Pharmaceuticals  vs.  LENZ Therapeutics

X4 Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days X4 Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in November 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

LENZ Therapeutics

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in LENZ Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, LENZ Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with X4 Pharmaceuticals and LENZ Therapeutics

The main advantage of trading using opposite X4 Pharmaceuticals and LENZ Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, LENZ Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LENZ Therapeutics will offset losses from the drop in LENZ Therapeutics' long position.

The idea behind X4 Pharmaceuticals and LENZ Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.